ACE2 and COVID-19: Asthma itself does not increase the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and previous studies have suggested a negative association between asthma and COVID-19, possibly because of decreased angiotensin-converting enzyme 2 (ACE2) receptors found in patients with asthma (23, 24).